Home › Funds › Deep Track Capital, LP › ACRS

Deep Track Capital, LP position in ACRS

ACLARIS THERAPEUTICS INC · Health Care

Deep Track Capital, LP reported holding 9,345,000 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$49.4M, representing 0.74% of its reported portfolio and ranking #39 among its reported holdings. Deep Track Capital, LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)9.35M sh
Reported value held$49.44M
Portfolio Weight0.74%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Deep Track Capital, LP's ACRS position evolved

Deep Track Capital, LP first disclosed a stake in ACRS in Q1 2026 at 9,345,000 shares (US$35.0M). The position peaked in Q2 2026 at 9,345,000 shares, worth US$49.4M. Across 2 filings, Deep Track Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 9,345,000 shares valued at US$49.4M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 9.35M $35.04M New
Q2 2026 9.35M $49.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACRS and 13F data

ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$63.3M), Vivo Capital, LLC (US$35.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACRS

All ACRS fund holders →

FAQ

How long has Deep Track Capital, LP held ACRS?

Deep Track Capital, LP has disclosed ACRS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Deep Track Capital, LP's current position in ACRS?

As of Q2 2026, Deep Track Capital, LP holds 9.35M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $49.44M, representing 0.74% of its reported portfolio and ranking #39.

Has Deep Track Capital, LP been buying or selling ACRS?

In the latest 13F filing (Q2 2026), Deep Track Capital, LP held unchanged its position in ACRS. The position peaked in Q2 2026 at 9.35M shares.

Which other funds hold ACRS?

Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Vivo Capital, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.